Start for free
Start for free
Hanmi Pharmaceutical logo

Hanmi Pharmaceutical

Asia, Seoul-t'ukpyolsi, South Korea, Seoul

Description

Established in 1973 in Korea, Hanmi Pharmaceuticals now is one of the top 5 pharmaceutical companies in terms of revenue, and the most R&D

Investor Profile

Hanmi Pharmaceutical has made 4 investments, with 2 in the past 12 months and 25% as lead.

Stage Focus

  • Seed (50%)
  • Post Ipo Debt (25%)
  • Corporate Round (25%)

Country Focus

  • United States (75%)
  • Canada (25%)

Industry Focus

  • Biotechnology
  • Health Care
  • Health Diagnostics
  • Biopharma
  • Artificial Intelligence (Ai)
  • Enterprise Software
  • Machine Learning
  • Medical
  • Software
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Hanmi Pharmaceutical frequently co-invest with?

Arkitekt Ventures
Arkitekt Ventures
North America, New York, United States, New York
Co-Investments: 1
Pegasus Tech Ventures
Pegasus Tech Ventures
North America, California, United States, San Jose
Co-Investments: 1
Soma Capital
Soma Capital
North America, California, United States, San Francisco
Co-Investments: 1
Lanza Tech Ventures
Lanza Tech Ventures
North America, California, United States, Palo Alto
Co-Investments: 1
UpHonest Capital
UpHonest Capital
North America, California, United States, Palo Alto
Co-Investments: 1
Seven Seas Partners
Seven Seas Partners
North America, California, United States, Menlo Park
Co-Investments: 1
AAF Management Ltd.
AAF Management Ltd.
North America, District of Columbia, United States, Washington
Co-Investments: 1
Kapor Capital
Kapor Capital
North America, California, United States, Oakland
Co-Investments: 1
DHVC
DHVC
North America, California, United States, Palo Alto
Co-Investments: 1
IT-Farm
IT-Farm
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1

Which angels does Hanmi Pharmaceutical often collaborate with?

WG
Wei Guo
North America, California, United States, San Francisco
Shared Deals: 1
MB
Marc Benioff
North America, California, United States, San Francisco
Shared Deals: 1
EC
Evan Cheng
North America, California, United States, Burlingame
Shared Deals: 1

What are some of recent deals done by Hanmi Pharmaceutical?

MEDiC

San Carlos, California, United States

MEDiC is focusing on cancer drug targets in 3D tumor models using its proprietary CRISPR functional genomics platform.

BiopharmaBiotechnologyLife Science
Corporate RoundOct 14, 2024
Amount Raised: $5,000,000
Aptose Biosciences

Toronto, Ontario, Canada

Aptose Biosciences is a biopharmaceutical company focused on the discovery, research and development of novel, first-in-class

BiopharmaBiotechnologyClinical Trials
Post Ipo DebtAug 30, 2024
Amount Raised: $7,411,525
Bloomlife

San Francisco, California, United States

Women's health company redefining maternal care delivery to improve the health of women and babies.

Health CareHealth DiagnosticsMedical DeviceWearables
SeedJul 17, 2018
Amount Raised: $4,500,000
Darmiyan

San Francisco, California, United States

Darmiyan is developing an AI-powered software platform for early detection, monitoring, and stratification of Alzheimer's disease

Artificial Intelligence (AI)BiotechnologyEnterprise SoftwareHealth CareHealth DiagnosticsMachine LearningMedicalSoftware
SeedOct 1, 2017
Amount Raised: $3,700,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator